Innate Pharma Obtains €28.7m in Non-Dilutive Financing in the Form of State Guaranteed
Financing strengthens Company’s cash horizonMARSEILLE, France, January 05, 2022--(BUSINESS WIRE)--Regulatory News:Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced that it has obtained…